Objectives

After participating in this educational activity, attendees should be able to:
1| Interpret hepatitis B serologies correctly and identify candidates for therapy
2| Recognize hepatitis B and screen appropriately
3| Discuss the goals of therapy both with currently approved and emerging therapies

 

Presenter(s): 

Paul Y. Kwo, MD
Professor of Medicine, Stanford University School of Medicine
Director of Hepatology, Department of Medicine, Stanford University
 
NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Paul Y. Kwo, MD    Speaker 
  • Advisory Board- Aligios, Arbutus, Amgen, Gilead, HepQuant, NovoNordisk, PB Gene
  • Contracted Research- Altimmune, Ausper Bio, Gilead, Inventiva, Madrigal, NovoNordisk, Saliz, Takeda, Target Registries, Ultragenyx
  • Consultant, Stock Options- Durect, Genentech, Inventiva, Mirum, Surrozen, Tune Therapeutics
No
Session date: 
02/26/2025 - 8:00am to 9:00am EST
Location: 
Baystate Medical Center
759 Chestnut Street
Webinar only
Springfield, MA 01199
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AAPA Category 1 CME credit
    Baystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
  • 1.00 ACPE Contact Hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 IPCE Credit Hour(s)

Please login or register to take this course.